For the next installment of his "Diamonds of the Dow" series, Cramer recommended
(KFT), the household name that rose 17.6% last year and sports a 3.1% dividend yield.
Cramer said while Kraft delivered strong results last quarter, the real value lies in its plans to split itself into two companies by the end of this year. As it's currently configured, Kraft is simply too big and diverse for investors to wrap their arms around, said Cramer.
The stock grows too slowly for the growth investors to get excited and the company isn't in the wheelhouse of the value investors either, leaving it in a stock no-man's-land, he explained.
But that all changed last year when Kraft announced that it's splitting into a fast-growing global snack foods business and a slower-growing domestic grocery business. On the surface, investors would think that food is food, but that's not the case, said Cramer.
He explained that grocery items and snack foods have totally different distribution models, different margins and most importantly, different growth prospects. The real value, he said, will be unlocked after these two entities are separated.
Cramer said he expects shares of Kraft to be propelled higher throughout this year as anticipation of the break-up builds. Until then, the company will continue to pay its juicy 3.1% dividend, making the deal even sweeter.
Continuing with his "Stock Super Bowl" series, it was play-off night for the top two performing
(ROST - Get Report)
(ALXN - Get Report)
, to see which company will square off against Cramer's
Dow Jones Industrial Average
Cabot Oil & Gas
, from last night's show.
Cramer said that on the surface it may seem difficult to compare an orphan drug maker with a discount retailer, but some metrics span every sector. His first match-up was the companies' PEG ratios, which compare their multiples vs. their growth rates. Ross Stores may seem like the cheaper play at just 14.9 times earnings, but when factoring in growth, it's a draw, said Cramer. Alexion's PEG ratio is 1.2 while Ross Stores had a PEG ratio of 1.4.
Cramer's next category was takeover potential. Here he said Alexion has the edge, as there simply aren't that many acquirers for Ross. In biotech, however, the possibilities are endless, he said.
Next, Cramer looked at surprise catalysts for these two contenders. He said that Ross Stores is able to take market share and has some exciting new store concepts, but that's nothing that investors aren't already expecting. Alexion on the other hand, has not only new drugs in its pipeline, but is also developing new indications for many of its existing drugs as well. Advantage Alexion, said Cramer.
Finally, on the defensive side, Cramer looked at dividends, where Ross Stores came out the clear winner with its 1.8% yield. Alexion is a growth stock, said Cramer, and all of its profits will go right back into research and development.
Tallying up the results, Cramer said that Alexion came out ahead by a hair, with a score of eight points to Ross' seven points. He said that Alexion will take on Cabot Oil & Gas in the stock Super Bowl on Friday's show.